Erythropoiesis-Stimulating Agents and Mortality

J Am Soc Nephrol. 2019 Jun;30(6):907-908. doi: 10.1681/ASN.2019030266. Epub 2019 Apr 23.

Tilman B Drüeke¹, Ziad A Massy^{2

3}

¹ Inserm U-1018, Team 5, Centre de recherche en épidémiologie et santé des populations, Versailles Saint-Quentin-en-Yvelines University (Paris-Ile-de-France-Ouest University), Paris-Sud University, and Paris Saclay University, Villejuif, France; and [email protected].
² Inserm U-1018, Team 5, Centre de recherche en épidémiologie et santé des populations, Versailles Saint-Quentin-en-Yvelines University (Paris-Ile-de-France-Ouest University), Paris-Sud University, and Paris Saclay University, Villejuif, France; and.
³ Division of Nephrology, Ambroise Paré Hospital, Assistance Publique-Hôpitaux de Paris, Boulogne Billancourt, Paris, France.

No abstract available

Keywords: anemia; chronic renal disease; erythropoietin; mortality risk; outcomes.

Publication types